- Home
- MBRX vs EKSO Comparison
MBRX vs EKSO Comparison
Compare MBRX & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- EKSO
- Stock Information
- Founded
- MBRX 2015
- EKSO 2005
- Country
- MBRX United States
- EKSO United States
- Employees
- MBRX N/A
- EKSO N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- MBRX Health Care
- EKSO Health Care
- Exchange
- MBRX Nasdaq
- EKSO Nasdaq
- Market Cap
- MBRX 12.9M
- EKSO 11.7M
- IPO Year
- MBRX 2016
- EKSO N/A
- Fundamental
- Price
- MBRX $0.31
- EKSO $3.44
- Analyst Decision
- MBRX Strong Buy
- EKSO Strong Buy
- Analyst Count
- MBRX 3
- EKSO 2
- Target Price
- MBRX $5.33
- EKSO $37.50
- AVG Volume (30 Days)
- MBRX 5.2M
- EKSO 260.6K
- Earning Date
- MBRX 08-13-2025
- EKSO 07-28-2025
- Dividend Yield
- MBRX N/A
- EKSO N/A
- EPS Growth
- MBRX N/A
- EKSO N/A
- EPS
- MBRX N/A
- EKSO N/A
- Revenue
- MBRX N/A
- EKSO $17,544,000.00
- Revenue This Year
- MBRX N/A
- EKSO $0.20
- Revenue Next Year
- MBRX N/A
- EKSO $42.29
- P/E Ratio
- MBRX N/A
- EKSO N/A
- Revenue Growth
- MBRX N/A
- EKSO N/A
- 52 Week Low
- MBRX $0.25
- EKSO $2.73
- 52 Week High
- MBRX $4.71
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- MBRX 24.39
- EKSO 39.67
- Support Level
- MBRX $0.25
- EKSO $2.73
- Resistance Level
- MBRX $0.42
- EKSO $4.03
- Average True Range (ATR)
- MBRX 0.06
- EKSO 0.34
- MACD
- MBRX -0.03
- EKSO 0.00
- Stochastic Oscillator
- MBRX 13.07
- EKSO 46.67
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.